Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders

Details for Australian Patent Application No. 2012203164 (hide)

Owner Janssen Pharmaceutica, N.V.

Inventors Parker, Michael N.; Reitz, Allen B.; Maryanoff, Bruce E.; McComsey, David F.

Agent Shelston IP

Pub. Number AU-A-2012203164

Parent 2005262497

Filing date 29 May 2012

Wipo publication date 21 June 2012

International Classifications

C07D 321/08 Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups

A61K 31/353

A61K 31/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/36

C07D 311/58 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 319/20 Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

14 June 2012 Complete Application Filed

21 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203164

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203165-Compression device having a pause feature

2012203163-Suggesting and/or providing targeting information for advertisements